Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P36
Within normal range
vs 5Y Ago
-0.8x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-10.08%
Q2 2025-8.81%
Q1 2025-7.45%
Q4 2024-3.82%
Q3 2024-7.43%
Q2 2024-5.74%
Q1 2024-5.37%
Q4 2023-5.35%
Q3 2023-6.15%
Q2 2023-6.75%
Q1 2023-5.94%
Q4 2022-2.52%
Q3 2022-5.46%
Q2 2022-2.49%
Q1 2022-2.68%
Q4 2021-1.23%
Q3 2021-1.95%
Q2 20213.39%
Q1 2021229.33%
Q4 2020274.54%
Q3 202012.07%
Q2 2020-13.60%
Q1 2020-18.54%
Q4 2019-12.63%
Q3 2019-10.82%
Q2 2019-11.49%
Q1 201979.39%
Q4 2018-17.02%
Q3 2018-14.80%
Q2 2018177.21%
Q1 2018-26.75%
Q4 2017124.62%
Q3 2017-22.82%
Q2 2017104.47%
Q1 2017-44.43%
Q4 2016-33.99%
Q3 201691.14%
Q2 2016-35.60%
Q1 2016-18.31%
Q4 2015-49.48%